N ‐terminal pro‐brain natriuretic peptide (NT‐proBNP) predicts the cardio‐renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - August 6, 2018 Category: Endocrinology Authors: Nienke M. A. Idzerda MD , Frederik Persson PhD , Michelle J. Pena PhD , Barry M. Brenner PhD , Patrick Brunel MD , Nish Chaturvedi PhD , John J. McMurray PhD , Hans ‐Henrik Parving PhD , Dick de Zeeuw PhD , Hiddo J Source Type: research